Skip to main content
SpringerLink
Log in

Induction of Tolerogenic Dendritic Cells by Vitamin D Receptor Agonists

  • Chapter
Dendritic Cells

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 188))

Abstract

Dendritic cells induce and regulate T cell responses, and tolerogenic dendritic cells (DCs) can promote the development of regulatory T cells with suppressive activity. Thus, the possibility to manipulate DCs using different pharmacological or biological agents enables them to exert tolerogenic activities, could be exploited to better control a variety of chronic inflammatory conditions, from autoimmune diseases to allograft rejection. A variety of both biological and pharmacological agents can induce tolerogenic DCs, and several in vitro studies have demonstrated that human regulatory T cells can be induced by DCs manipulated to acquire and/or enhance tolerogenic properties, with in vivo data also accumulating. Within this context, we have explored the immunoregulatory activities of vitamin D receptor (VDR) agonists, secosteroid hormones able to induce tolerogenic DCs and regulatory T cells. Tolerogenic DCs induced by a short treatment with VDR agonists promote CD4+ CD25+ Foxp3+ suppressor T cells that are able to mediate transplantation tolerance and to arrest the development of autoimmune diseases. VDR agonists not only favour the induction of CD4+ CD25+ regulatory T cells, but can also enhance their recruitment to inflammatory sites. VDR agonists have been proven effective and safe drugs in a variety of autoimmune disease and graft rejection models, highlighting their potential applicability to chronic inflammatory conditions sustained by autoreactive or alloreactive immune responses. In addition to the topical treatment of psoriasis, a Th1-mediated autoimmune disease of the skin where VDR agonists are the most used topical drugs; these agents might eventually find a broader application in the treatment of inflammatory conditions, where their modulatory effects on DCs enhancing T cells with regulatory functions could turn out to be quite beneficial.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adorini L (2002a) Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. Int Immunopharmacol 2:1017–1028

    Article  CAS  Google Scholar 

  • Adorini L (2002b) 1,25-Dihydroxyvitamin D3 analogs as potential therapies in transplantation. Curr Opin Invest Drugs 3:1458–1463

    CAS  Google Scholar 

  • Adorini L, Giarratana N, Penna G (2004) Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin Immunol 16:127–134

    Article  PubMed  CAS  Google Scholar 

  • Adorini L and Penna G (2008) Control of autoimmune disease by the vitamin D endocrine system. Nat Clin Pract Rheumatol 4(8):404–412

    Article  PubMed  CAS  Google Scholar 

  • Allison AC (2000) Immunosuppressive drugs: the first 50 years and a glance forward. Im-munopharmacology 47:63–83

    CAS  Google Scholar 

  • Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by gluco-corticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286–290

    Article  PubMed  CAS  Google Scholar 

  • Baecher-Allan C, Hafler DA (2006) Human regulatory T cells and their role in autoimmune disease. Immunol Rev 212:203–216

    Article  PubMed  CAS  Google Scholar 

  • Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, de Waal-Malefyt R, Coffman RL, Hawrylowicz CM, O'Garra A (2002) In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 195:603–616

    Article  PubMed  CAS  Google Scholar 

  • Berer A, Stockl J, Majdic O, Wagner T, Kollars M, Lechner K, Geissler K, Oehler L (2000) 1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol 28:575–583

    Article  PubMed  CAS  Google Scholar 

  • Bonizzi G, Karin M (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25:280–288

    Article  PubMed  CAS  Google Scholar 

  • Buckland M, Jago C, Fazekesova H, George A, Lechler R, Lombardi G (2006a) Aspirin modified dendritic cells are potent inducers of allo-specific regulatory T-cells. Int Immunopharmacol 6:1895–1901

    Article  CAS  Google Scholar 

  • Buckland M, Jago CB, Fazekasova H, Scott K, Tan PH, George AJ, Lechler R, Lombardi G (2006b) Aspirin-treated human DCs up-regulate ILT-3 and induce hyporesponsiveness and regulatory activity in responder T cells. Am J Transplant 6:2046–2059

    Article  CAS  Google Scholar 

  • Canning MO, Grotenhuis K, de Wit H, Ruwhof C, Drexhage HA (2001) 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur J Endocrinol 145:351–357

    Article  PubMed  CAS  Google Scholar 

  • Carlberg C (2003) Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands. Recent Results Cancer Res 164:29–42

    PubMed  CAS  Google Scholar 

  • Cella M, Dohring C, Samaridis J, Dessing M, Brockhaus M, Lanzavecchia A, Colonna M (1997) A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med 185:1743–1751

    Article  PubMed  CAS  Google Scholar 

  • Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanzavecchia A, Colonna M (1999) Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 5:919–923

    Article  PubMed  CAS  Google Scholar 

  • Chang CC, Ciubotariu R, Manavalan JS, Yuan J, Colovai AI, Piazza F, Lederman S, Colonna M, Cortesini R, Dalla-Favera R, Suciu-Foca N (2002) Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 3:237–243

    Article  PubMed  CAS  Google Scholar 

  • Chen X, Jensen PE (2007) Cutting edge: primary B lymphocytes preferentially expand allogeneic FoxP3+CD4 T cells. J Immunol 179:2046–2050

    PubMed  CAS  Google Scholar 

  • Chen S, Sims GP, Chen XX, Gu YY, Lipsky PE (2007) Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 179:1634–1647

    PubMed  CAS  Google Scholar 

  • Colic M, Stojic-Vukanic Z, Pavlovic B, Jandric D, Stefanoska I (2003) Mycophenolate mofetil inhibits differentiation, maturation and allostimulatory function of human monocyte-derived dendritic cells. Clin Exp Immunol 134:63–69

    Article  PubMed  CAS  Google Scholar 

  • Colonna M, Nakajima H, Navarro F, Lopez-Botet M (1999) A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. J Leukoc Biol 66:375–381

    PubMed  CAS  Google Scholar 

  • Colonna M, Nakajima H, Cella M (2000) A family of inhibitory and activating Ig-like receptors that modulate function of lymphoid and myeloid cells. Semin Immunol 12:121–127

    Article  PubMed  CAS  Google Scholar 

  • Colonna M, Trinchieri G, Liu YJ (2004) Plasmacytoid dendritic cells in immunity. Nat Immunol 5:1219–1226

    Article  PubMed  CAS  Google Scholar 

  • Contreras JL, Wang PX, Eckhoff DE, Lobashevsky AL, Asiedu C, Frenette L, Robbin ML, Hubbard WJ, Cartner S, Nadler S, Cook WJ, Sharff J, Shiloach J, Thomas FT, Neville DM, Jr., Thomas JM (1998) Peritransplant tolerance induction with anti-CD3-immunotoxin: a matter of proinflammatory cytokine control. Transplantation 65:1159–1169

    Article  PubMed  CAS  Google Scholar 

  • Cortesini R (2007) Pancreas cancer and the role of soluble immunoglobulin-like transcript 3 (ILT3). Jop 8:697–703

    PubMed  Google Scholar 

  • Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10: 942–949

    Article  PubMed  CAS  Google Scholar 

  • D'Ambrosio D, Sinigaglia F, Adorini L (2003) Special attractions for suppressor T cells. Trends Immunol 24:122–126

    Article  PubMed  CAS  Google Scholar 

  • Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM (2007) Immune modulatory treatment of TNBS colitis with calcitriol is associated with a change of a Th1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 324:23–33

    Article  PubMed  CAS  Google Scholar 

  • Deluca HF, Cantorna MT (2001) Vitamin D: its role and uses in immunology. Faseb J 15:2579– 2585

    Article  PubMed  CAS  Google Scholar 

  • Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N (2001) Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 193:233–238

    Article  PubMed  CAS  Google Scholar 

  • Dong X, Craig TA, Xing N, Bachman LA, Paya CV, Weih F, McKean DJ, Kumar R, Griffin MD (2003) Direct transcriptional regulation of RelB by 1alpha,25-dihydroxyvitamin D3 and its analogs: physiologic and therapeutic implications for dendritic cell function. J Biol Chem 278:49378–49385

    Article  PubMed  CAS  Google Scholar 

  • Fallarino F, Gizzi S, Mosci P, Grohmann U, Puccetti P (2007) Tryptophan catabolism in IDO + plasmacytoid dendritic cells. Curr Drug Metab 8:209–216

    Article  PubMed  CAS  Google Scholar 

  • Fogel-Petrovic M, Long JA, Misso NL, Foster PS, Bhoola KD, Thompson PJ (2007) Physiological concentrations of transforming growth factor beta1 selectively inhibit human dendritic cell function. Int Immunopharmacol 7:1924–1933

    Article  PubMed  CAS  Google Scholar 

  • Franzke A, Piao W, Lauber J, Gatzlaff P, Konecke C, Hansen W, Schmitt-Thomsen A, Hertenstein B, Buer J, Ganser A (2003) G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases. Blood 102:734– 739

    Article  CAS  Google Scholar 

  • Frigerio S, Junt T, Lu B, Gerard C, Zumsteg U, Hollander GA, Piali L (2002) Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat Med 8:1414–1420

    Article  PubMed  CAS  Google Scholar 

  • Game DS, Hernandez-Fuentes MP, Lechler RI (2005) Everolimus and Basiliximab Permit Suppression by Human CD4CD25 Cells in vitro. Am J Transplant 5:454–464

    Article  PubMed  CAS  Google Scholar 

  • Giarratana N, Penna G, Amuchastegui S, Mariani R, Daniel KC, Adorini L (2004) A vitamin D analog downregulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development. J Immunol 173:2280–2287

    PubMed  CAS  Google Scholar 

  • Giarratana N, Penna G, Adorini L (2007) Animal models of spontaneous autoimmune disease: type 1 diabetes in the nonobese diabetic mouse. Methods Mol Biol 380:285–312

    Article  PubMed  CAS  Google Scholar 

  • Gilliet M, Liu YJ (2002) Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 195:695–704

    Article  PubMed  CAS  Google Scholar 

  • Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L (2001) Regulatory T cells induced by 1α, 25-Dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 167:1945–1953

    PubMed  CAS  Google Scholar 

  • Gregori G, Giarratana N, Smiroldo S, Uskokovic M, Adorini L (2002) A 1(,25-Dihydroxyvitamin D3 analog enhances regulatory T cells and arrests autoimmune diabetes in NOD mice. Diabetes 51:1367–1374

    Article  PubMed  CAS  Google Scholar 

  • Griffin MD, Lutz WH, Phan VA, Bachman LA, McKean DJ, Kumar R (2000) Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem Biophys Res Commun 270:701–708

    Article  PubMed  CAS  Google Scholar 

  • Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R (2001) Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci USA 22:22

    Google Scholar 

  • Griffin MD, Xing N, Kumar R (2003) Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu Rev Nutr 23:117–145

    Article  PubMed  CAS  Google Scholar 

  • Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737–742

    Article  PubMed  CAS  Google Scholar 

  • Hackstein H, Thomson AW (2004) Dendritic cells: emerging pharmacological targets of immuno-suppressive drugs. Nat Rev Immunol 4:24–34

    Article  PubMed  CAS  Google Scholar 

  • Hackstein H, Morelli AE, Larregina AT, Ganster RW, Papworth GD, Logar AJ, Watkins SC, Falo LD, Thomson AW (2001) Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells. J Immunol 166:7053–7062

    PubMed  CAS  Google Scholar 

  • Hackstein H, Taner T, Zahorchak AF, Morelli AE, Logar AJ, Gessner A, Thomson AW (2003) Rapamycin inhibits IL-4 — induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. Blood 101:4457–4463

    Article  PubMed  CAS  Google Scholar 

  • Hewison M, Freeman L, Hughes SV, Evans KN, Bland R, Eliopoulos AG, Kilby MD, Moss PA, Chakraverty R (2003) Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 170:5382–5390

    PubMed  CAS  Google Scholar 

  • Hontecillas R, Bassaganya-Riera J (2007) Peroxisome proliferator-activated receptor gamma is required for regulatory CD4+ T cell-mediated protection against colitis. J Immunol 178:2940– 2949

    PubMed  CAS  Google Scholar 

  • Izawa A, Sayegh MH, Chandraker A (2004) The antagonism of calcineurin inhibitors and costim-ulatory blockers: fact or fiction? Transplant Proc 36:570S–573S

    Article  PubMed  CAS  Google Scholar 

  • Kared H, Masson A, Adle-Biassette H, Bach JF, Chatenoud L, Zavala F (2005) Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacy-toid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells. Diabetes 54:78–84

    Article  PubMed  CAS  Google Scholar 

  • Klotz L, Dani I, Edenhofer F, Nolden L, Evert B, Paul B, Kolanus W, Klockgether T, Knolle P, Diehl L (2007) Peroxisome proliferator-activated receptor gamma control of dendritic cell function contributes to development of CD4+ T cell anergy. J Immunol 178:2122–2131

    PubMed  CAS  Google Scholar 

  • Lagaraine C, Lebranchu Y (2003) Effects of immunosuppressive drugs on dendritic cells and tolerance induction. Transplantation 75:37S–42S

    Article  PubMed  Google Scholar 

  • Lee JI, Ganster RW, Geller DA, Burckart GJ, Thomson AW, Lu L (1999) Cyclosporine A inhibits the expression of costimulatory molecules on in vitro-generated dendritic cells: association with reduced nuclear translocation of nuclear factor kappa B. Transplantation 68:1255–1263

    Article  PubMed  CAS  Google Scholar 

  • Li Q, Verma IM (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2:725–734

    Article  PubMed  CAS  Google Scholar 

  • Liu YJ (2005) IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23:275–306

    Article  PubMed  CAS  Google Scholar 

  • Liu J, Liu Z, Witkowski P, Vlad G, Manavalan JS, Scotto L, Kim-Schulze S, Cortesini R, Hardy MA, Suciu-Foca N (2004) Rat CD8 + FOXP3 + T suppressor cells mediate tolerance to allo-geneic heart transplants, inducing PIR-B in APC and rendering the graft invulnerable to rejection. Transpl Immunol 13:239–247

    Article  PubMed  CAS  Google Scholar 

  • Lutz MB, Schuler G (2002) Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 23:445–449

    Article  PubMed  CAS  Google Scholar 

  • Lutz MB, Suri RM, Niimi M, Ogilvie AL, Kukutsch NA, Rossner S, Schuler G, Austyn JM (2000) Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol 30:1813–1822

    Article  PubMed  CAS  Google Scholar 

  • Lyakh LA, Sanford M, Chekol S, Young HA, Roberts AB (2005) TGF-{beta} and Vitamin D3 Utilize Distinct Pathways to Suppress IL-12 Production and Modulate Rapid Differentiation of Human Monocytes into CD83+ Dendritic Cells. J Immunol 174:2061–2070

    PubMed  CAS  Google Scholar 

  • Manavalan JS, Rossi PC, Vlad G, Piazza F, Yarilina A, Cortesini R, Mancini D, Suciu-Foca N (2003) High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl Immunol 11:245–258

    Article  PubMed  CAS  Google Scholar 

  • Manavalan JS, Kim-Schulze S, Scotto L, Naiyer AJ, Vlad G, Colombo PC, Marboe C, Mancini D, Cortesini R, Suciu-Foca N (2004) Alloantigen specific CD8 +CD28 -FOXP3 +T suppressor cells induce ILT3 +ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. Int Immunol 16:1055–1068

    Article  PubMed  CAS  Google Scholar 

  • Martin E, O'Sullivan B, Low P, Thomas R (2003) Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. Immunity 18:155–167

    Article  PubMed  CAS  Google Scholar 

  • Matasic R, Dietz AB, Vuk-Pavlovic S (1999) Dexamethasone inhibits dendritic cell maturation by redirecting differentiation of a subset of cells. J Leukoc Biol 66:909–914

    PubMed  CAS  Google Scholar 

  • Matasic R, Dietz AB, Vuk-Pavlovic S (2000) Cyclooxygenase-independent inhibition of dendritic cell maturation by aspirin. Immunology 101:53–60

    Article  PubMed  CAS  Google Scholar 

  • Mathieu C, Adorini L (2002) The coming of age of 1,25-dihydroxyvitamin D(3) analogs as im-munomodulatory agents. Trends Mol Med 8:174–179.

    Article  PubMed  CAS  Google Scholar 

  • Mehling A, Grabbe S, Voskort M, Schwarz T, Luger TA, Beissert S (2000) Mycophenolate mofetil impairs the maturation and function of murine dendritic cells. J Immunol 165:2374–2381.

    PubMed  CAS  Google Scholar 

  • Mellor AL, Munn DH (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4:762–774

    Article  PubMed  CAS  Google Scholar 

  • Menges M, Rossner S, Voigtlander C, Schindler H, Kukutsch NA, Bogdan C, Erb K, Schuler G, Lutz MB (2002) Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med 195:15–21

    Article  PubMed  CAS  Google Scholar 

  • Millard AL, Mertes PM, Ittelet D, Villard F, Jeannesson P, Bernard J (2002) Butyrate affects differentiation, maturation and function of human monocyte-derived dendritic cells and macrophages. Clin Exp Immunol 130:245–255

    Article  PubMed  CAS  Google Scholar 

  • Miyara M, Sakaguchi S (2007) Natural regulatory T cells: mechanisms of suppression. Trends Mol Med 13:108–116

    Article  PubMed  CAS  Google Scholar 

  • Penna G, Adorini L (2000) 1,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164:2405–2411

    PubMed  CAS  Google Scholar 

  • Penna G, Sozzani S, Adorini L (2001) Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J Immunol 167:1862–1866

    PubMed  CAS  Google Scholar 

  • Penna G, Vulcano M, Roncari A, Facchetti F, Sozzani S, Adorini L (2002) Differential chemokine production by myeloid and plasmacytoid dendritic cells. J Immunol 169:6673–6676

    PubMed  CAS  Google Scholar 

  • Penna G, Roncari A, Amuchastegui S, Daniel KC, Berti E, Colonna M, Adorini L (2005) Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3. Blood 106:3490–3497

    Article  PubMed  CAS  Google Scholar 

  • Penna G, Amuchastegui S, Giarratana N, Daniel KC, Vulcano M, Sozzani S, Adorini L (2007) 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J Immunol 178:145–153

    PubMed  CAS  Google Scholar 

  • Piemonti L, Monti P, Allavena P, Sironi M, Soldini L, Leone BE, Socci C, Di Carlo V (1999) Glu-cocorticoids affect human dendritic cell differentiation and maturation. J Immunol 162:6473– 6481

    PubMed  CAS  Google Scholar 

  • Piemonti L, Monti P, Sironi M, Fraticelli P, Leone BE, Dal Cin E, Allavena P, Di Carlo V (2000) Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 164:4443–4451

    PubMed  CAS  Google Scholar 

  • Puccetti P, Fallarino F (2007) Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism. Blood Cells Mol Dis 40:101–105

    Article  PubMed  CAS  Google Scholar 

  • Puccetti P, Grohmann U (2007) IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation. Nat Rev Immunol 7:817–823

    Article  PubMed  CAS  Google Scholar 

  • Ravetch JV, Lanier LL (2000) Immune inhibitory receptors. Science 290:84–89

    Article  PubMed  CAS  Google Scholar 

  • Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK (2006) Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 212:28–50

    Article  PubMed  CAS  Google Scholar 

  • Rutella S, Lemoli RM (2004) Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications. Immunol Lett 94:11–26

    Article  PubMed  CAS  Google Scholar 

  • Rutella S, Pierelli L, Bonanno G, Sica S, Ameglio F, Capoluongo E, Mariotti A, Scambia G, d'Onofrio G, Leone G (2002) Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells. Blood 100:2562–2571

    Article  PubMed  CAS  Google Scholar 

  • Rutella S, Bonanno G, Pierelli L, Mariotti A, Capoluongo E, Contemi AM, Ameglio F, Curti A, De Ritis DG, Voso MT, Perillo A, Mancuso S, Scambia G, Lemoli RM, Leone G (2004) Gran-ulocyte colony-stimulating factor promotes the generation of regulatory DC through induction of IL-10 and IFN-alpha. Eur J Immunol 34:1291–1302

    Article  PubMed  CAS  Google Scholar 

  • Saemann MD, Kelemen P, Bohmig GA, Horl WH, Zlabinger GJ (2004) Hyporesponsiveness in alloreactive T-cells by NF-kappaB inhibitor-treated dendritic cells: resistance to calcineurin inhibition. Am J Transplant 4:1448–1458

    Article  PubMed  CAS  Google Scholar 

  • Sato K, Yamashita N, Baba M, Matsuyama T (2003) Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity 18:367–379

    Article  PubMed  CAS  Google Scholar 

  • Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS, Jr. (1995) Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270:283–286

    Article  PubMed  CAS  Google Scholar 

  • Shevach EM, DiPaolo RA, Andersson J, Zhao DM, Stephens GL, Thornton AM (2006) The lifestyle of naturally occurring CD4 + CD25 + Foxp3 + regulatory T cells. Immunol Rev 212:60–73

    Article  PubMed  CAS  Google Scholar 

  • Shortman K, Liu YJ (2002) Mouse and human dendritic cell subtypes. Nat Rev Immunol 2: 151–161.

    Article  PubMed  CAS  Google Scholar 

  • Sigmundsdottir H, Pan J, Debes GF, Alt C, Habtezion A, Soler D, Butcher EC (2007) DCs metabolize sunlight-induced vitamin D3 to program' T cell attraction to the epidermal chemokine CCL27. Nat Immunol 8:285–293

    Article  PubMed  CAS  Google Scholar 

  • Steinman RM, Banchereau J (2007) Taking dendritic cells into medicine. Nature 449:419–426

    Article  PubMed  CAS  Google Scholar 

  • Steinman RM, Hemmi H (2006) Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 311:17–58

    Article  PubMed  CAS  Google Scholar 

  • Steinman RM, Hawiger D, Nussenzweig MC (2003) Tolerogenic dendritic cells. Annu Rev Immunol 21:685–711

    Article  PubMed  CAS  Google Scholar 

  • Suciu-Foca N, Cortesini R (2007) Central role of ILT3 in the T suppressor cell cascade. Cell Immunol 248:59–67

    Article  PubMed  CAS  Google Scholar 

  • Szabo G, Gavala C, Mandrekar P (2001) Tacrolimus and cyclosporine A inhibit allostimulatory capacity and cytokine production of human myeloid dendritic cells. J Invest Med 49:442–449

    Article  CAS  Google Scholar 

  • Takai T, Ono M (2001) Activating and inhibitory nature of the murine paired immunoglobulin-like receptor family. Immunol Rev 181:215–222

    Article  PubMed  CAS  Google Scholar 

  • Taner T, Hackstein H, Wang Z, Morelli AE, Thomson AW (2005) Rapamycin-treated, alloantigen-pulsed host dendritic cells induce ag-specific T cell regulation and prolong graft survival. Am J Transplant 5:228–236

    Article  PubMed  CAS  Google Scholar 

  • Terness P, Bauer TM, Rose L, Dufter C, Watzlik A, Simon H, Opelz G (2002) Inhibition of allo-geneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 196:447–457

    Article  PubMed  CAS  Google Scholar 

  • Thomas JM, Contreras JL, Jiang XL, Eckhoff DE, Wang PX, Hubbard WJ, Lobashevsky AL, Wang W, Asiedu C, Stavrou S, Cook WJ, Robbin ML, Thomas FT, Neville DM, Jr. (1999) Per-itransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin. Transplantation 68:1660–1673

    Article  PubMed  CAS  Google Scholar 

  • Thomas JM, Hubbard WJ, Sooudi SK, Thomas FT (2001) STEALTH matters: a novel paradigm of durable primate allograft tolerance. Immunol Rev 183:223–233

    Article  PubMed  CAS  Google Scholar 

  • van Halteren AG, van Etten E, de Jong EC, Bouillon R, Roep BO, Mathieu C (2002) Redirection of human autoreactive T-cells upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3). Diabetes 51:2119–2125

    Article  PubMed  Google Scholar 

  • Verhasselt V, Vanden Berghe W, Vanderheyde N, Willems F, Haegeman G, Goldman M (1999) N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kappaB inhibition. J Immunol 162:2569–2574

    PubMed  CAS  Google Scholar 

  • Vieira PL, Kalinski P, Wierenga EA, Kapsenberg ML, de Jong EC (1998) Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential. J Immunol 161:5245–5251

    PubMed  CAS  Google Scholar 

  • Vulcano M, Struyf S, Scapini P, Cassatella M, Bernasconi S, Bonecchi R, Calleri A, Penna G, Adorini L, Luini W, Mantovani A, Van Damme J, Sozzani S (2003) Unique regulation of CCL18 production by maturing dendritic cells. J Immunol 170:3843–3849

    PubMed  CAS  Google Scholar 

  • Wohlfert EA, Nichols FC, Nevius E, Clark RB (2007) Peroxisome proliferator-activated receptor gamma (PPARgamma) and immunoregulation: enhancement of regulatory T cells through PPARgamma-dependent and -independent mechanisms. J Immunol 178:4129–4135

    PubMed  CAS  Google Scholar 

  • Woltman AM, van Kooten C (2003) Functional modulation of dendritic cells to suppress adaptive immune responses. J Leukoc Biol 73:428–441

    Article  PubMed  CAS  Google Scholar 

  • Woltman AM, de Fijter JW, Kamerling SW, Paul LC, Daha MR, van Kooten C (2000) The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur J Immunol 30:1807–1812

    Article  PubMed  CAS  Google Scholar 

  • Woltman AM, de Fijter JW, Kamerling SW, van Der Kooij SW, Paul LC, Daha MR, van Kooten C (2001) Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages. Blood 98:174–180

    Article  PubMed  CAS  Google Scholar 

  • Xie JH, Nomura N, Lu M, Chen SL, Koch GE, Weng Y, Rosa R, Di Salvo J, Mudgett J, Peterson LB, Wicker LS, DeMartino JA (2003) Antibody-mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation. J Leukoc Biol 73:771–780

    Article  PubMed  CAS  Google Scholar 

  • Xing N, ML LM, Bachman LA, McKean DJ, Kumar R, Griffin MD (2002) Distinctive dendritic cell modulation by vitamin D(3) and glucocorticoid pathways. Biochem Biophys Res Commun 297:645–652

    Article  PubMed  CAS  Google Scholar 

  • Yamazaki S, Iyoda T, Tarbell K, Olson K, Velinzon K, Inaba K, Steinman RM (2003) Direct expansion of functional CD25+CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med 198:235–247

    Article  PubMed  CAS  Google Scholar 

  • Yamazaki S, Bonito AJ, Spisek R, Dhodapkar M, Inaba K, Steinman RM (2007) Dendritic cells are specialized accessory cells along with TGF-{beta} for the differentiation of Foxp3+CD4+ regulatory T cells from peripheral Foxp3- precursors. Blood 110:4293–4302

    Article  PubMed  CAS  Google Scholar 

  • Yokoyama WM (1997) What goes up must come down: the emerging spectrum of inhibitory receptors. J Exp Med 186:1803–1808

    Article  PubMed  CAS  Google Scholar 

  • Yu XP, Bellido T, Manolagas SC (1995) Down-regulation of NF-kappa B protein levels in activated human lymphocytes by 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 92:10990–10994

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Intercept Pharma, Via Togliatti 22 bis, 06073, Corciano (Perugia), Italy

    Luciano Adorini

  2. BioXell, Via Olgettina, Milano, 58, 20132, Italy

    Giuseppe Penna

Authors
  1. Luciano Adorini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giuseppe Penna
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. DIIID, King's College, London School of Medicine, Guy's Hospital, London, UK

    Giovanna Lombardi (Professor of Human Transplant Immunology MRC Centre in Transplantation Dep. of Nephrology and Transplantation) (Professor of Human Transplant Immunology MRC Centre in Transplantation Dep. of Nephrology and Transplantation)

  2. 5th Floor Hodgkin Building, School of Biomedical and Health Sciences, King's College London, London, SE1 1UL, United Kingdom

    Yanira Riffo-Vasquez (Research Fellow The Sackler Institute of Pulmonary Pharmacology Pharmaceutical Science Division) (Research Fellow The Sackler Institute of Pulmonary Pharmacology Pharmaceutical Science Division)

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Adorini, L., Penna, G. (2009). Induction of Tolerogenic Dendritic Cells by Vitamin D Receptor Agonists. In: Lombardi, G., Riffo-Vasquez, Y. (eds) Dendritic Cells. Handbook of Experimental Pharmacology, vol 188. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-71029-5_12

Download citation

Publish with us

Policies and ethics

Search

Navigation